Our genes are not our destiny: incorporating molecular medicine into clinical practice.
In many developed nations, the state of publicly administered health care is increasingly precarious as a result of escalating numbers of chronically ill patients, inadequate medical personnel and hospital facilities, as well as sparse funding for ongoing upgrades to state-of-the-art diagnostic and therapeutic technology - an increased emphasis on aetiology-centred medicine should be considered in order to achieve improved health for patients and populations. Medical practice patterns which are designed to provide quick and effective amelioration of signs and symptoms are frequently not an enduring solution to many health afflictions and chronic disease states. Recent scientific discovery has rendered the drug-oriented algorithmic paradigm commonly found in contemporary evidence-based medicine to be a reductionist approach to clinical practice. Unfolding evidence appears to support a genetic predisposition model of health and illness rather than a fatalistic predestination construct - modifiable epigenetic and environmental factors have enormous potential to influence clinical outcomes. By understanding and applying fundamental clinical principles relating to the emerging fields of molecular medicine, nutrigenomics and human exposure assessment, doctors will be empowered to address causality of affliction when possible and achieve sustained reprieve for many suffering patients.
Genuis
Stephen J
SJ
Faculty of Medicine, The University of Alberta, Edmonton, AB, Canada. sgenuis@ualberta.ca
D015510:Clinical Medicine / Q000458:organization & administration*; D019317:Evidence-Based Medicine; D005820:Genetic Testing; D015894:Genome, Human; D006291:Health Policy; D006801:Humans; D008967:Molecular Biology; D025202:Molecular Diagnostic Techniques; D010597:Pharmacogenetics